Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
90.1M
-
Shares change
-
+607K
-
Total reported value, excl. options
-
$4.1B
-
Value change
-
+$33.3M
-
Put/Call ratio
-
0.64
-
Number of buys
-
123
-
Number of sells
-
-86
-
Price
-
$45.58
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2021
264 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q4 2021.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.1M shares
of 119M outstanding shares and own 75.5% of the company stock.
Largest 10 shareholders include BlackRock Inc. (13M shares), FMR LLC (12.5M shares), VANGUARD GROUP INC (6.99M shares), STATE STREET CORP (3.99M shares), Polar Capital Holdings Plc (3.67M shares), PICTET ASSET MANAGEMENT SA (2.6M shares), RTW INVESTMENTS, LP (2.56M shares), PFM Health Sciences, LP (2.47M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.33M shares), and WASATCH ADVISORS INC (2.18M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.